Trials / Unknown
UnknownNCT03232502
Pharmacogenetics in Primary Care Psychotropics
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 130 (estimated)
- Sponsor
- University of Arizona · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Pragmatic trial of pharmacogenetic testing at the time of prescription for a selective serotonin reuptake inhibitor, tricyclic antidepressant or atypical antipsychotic. Does real time intervention improve patient outcomes?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Pharmacogenetic testing | Basic pharmacogenetic panel |
Timeline
- Start date
- 2017-08-15
- Primary completion
- 2018-01-15
- Completion
- 2018-12-31
- First posted
- 2017-07-28
- Last updated
- 2017-07-28
Source: ClinicalTrials.gov record NCT03232502. Inclusion in this directory is not an endorsement.